Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $283

HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $283

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $298 to $283.

byBenzinga Newsdesk

July 11, 2022

1 minute read

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $298 to $283.

Truist Securities Maintains Buy on Equity Residential, Raises Price Target to $70

By Benzinga Newsdesk

March 10, 10:29 AM

Truist Securities analyst Michael Lewis maintains Equity Residential (NYSE:EQR) with a Buy and raises the price target from $68 to $70.

EQR

Norwegian Cruise Line On ‘PreMarket Prep’: Charting The Plunge

By Joel Elconin

August 9, 3:54 PM

Several issues have rebounded nicely off their pandemic lows only to peak and come back down to levels not seen since mid-2020.

NCLH

Analyst Ratings

Where Stryker Stands With Analysts

By Benzinga Insights

July 11, 5:12 PM

Stryker (NYSE:SYK) has observed the following analyst ratings within the last quarter:

SYK

Workhorse Group Receives First Fleet Order For W56 Step Van; No Financial Terms Disclosed

By Benzinga Newsdesk

December 20, 9:32 AM

Workhorse Group Inc. (Nasdaq: WKHS) ("Workhorse" or "the Company"), an American technology company focused on pioneering the transition to zero emission commercial vehicles, today announced it has received its first

WKHS

HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $283

Related Posts

Truist Securities Maintains Buy on Equity Residential, Raises Price Target to $70

Norwegian Cruise Line On ‘PreMarket Prep’: Charting The Plunge

Where Stryker Stands With Analysts

Workhorse Group Receives First Fleet Order For W56 Step Van; No Financial Terms Disclosed